Clinical Trial Highlights

• Disease Activity Assessment in Polymyalgia Rheumatica (PMR)
• Results from the Long-Term Extension of the AIM Trial
• The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors
• Efficacy and Safety of Tocilizumab in Monotherapy, an Anti-II-6 Receptor Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis: Results from a 24 Week Double-Blind Phase III Study
• Concomitant Aspirin Use Reduces the Risk of Acute Myocardial Infarction in Users of Cyclooxygenase-2 Selective and Some Non-Selective Non-Steroidal Anti-Inflammatory Drugs
• 54 Week Results from IMPACT 2: Infliximab Inhibits Progression of Radiographic Damage in Patients with Active Psoriatic Arthritis
• The ATLAS Trial: Long-Term Adalimumab Treatment Reduces Signs and Symptoms in Ankylosing Spondylitis Patients
• The Clinical Efficacy and Safety of Subcutaneous Oral Application of Methotrexate in Patients with Active Rheumatoid Arthritis — Results of a Randomized, Controlled, Double-Blind, Multi-Center Study
• Intensive Treatment with MTX of Early Rheumatoid Arthritis Patients is Beneficial When Compared to Conventional Treatment with MTX: A Two Year Study